Lavo AI
Advanced AI-driven crystal structure prediction software to streamline drug development processes.
About Lavo AI
Lavo Life Sciences is an innovative, VC-backed startup specializing in software solutions for pharmaceutical research. Their AI-enhanced platform enables accurate crystal structure prediction for small molecules, helping to reduce development risks, optimize drug formulations, and prevent costly late-stage surprises. The web-based Crystal Console offers robust tools for crystal analysis, virtual polymorph screening, and PXRD data comparison, accelerating drug discovery workflows.
How to Use
Users can upload crystal data, visualize structures, and perform analysis seamlessly with Crystal Console’s user-friendly interface. The platform supports virtual polymorph screening, PXRD data comparison, and provides options to schedule a demo for detailed guidance.
Features
- Virtual polymorph screening for risk assessment
- PXRD data analysis and comparison
- AI-based crystal structure prediction accuracy
- Intuitive visualization of crystal structures
Use Cases
- Optimizing solid-state drug formulations for stability and manufacturability
- Identifying potential crystal form issues early in development
- Speeding up crystal form identification to save time and costs
Best For
Pros
- Supports faster decision-making in drug development
- Reduces risk of unexpected crystal forms delaying projects
- Speeds up crystal form identification process
- Enables discovery of novel polymorphs with improved properties
Cons
- Requires expertise in crystallography and computational chemistry for optimal use
- Prediction accuracy depends on input data quality